<SEC-DOCUMENT>0001213900-25-046434.txt : 20250521
<SEC-HEADER>0001213900-25-046434.hdr.sgml : 20250521
<ACCEPTANCE-DATETIME>20250521160104
ACCESSION NUMBER:		0001213900-25-046434
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20250521
FILED AS OF DATE:		20250521
DATE AS OF CHANGE:		20250521

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SciSparc Ltd.
		CENTRAL INDEX KEY:			0001611746
		STANDARD INDUSTRIAL CLASSIFICATION:	RETAIL-AUTO DEALERS & GASOLINE STATIONS [5500]
		ORGANIZATION NAME:           	07 Trade & Services
		EIN:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38041
		FILM NUMBER:		25973037

	BUSINESS ADDRESS:	
		STREET 1:		20 RAUL WALLENBERG STREET, TOWER A
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			6971916
		BUSINESS PHONE:		972-3-6103100

	MAIL ADDRESS:	
		STREET 1:		20 RAUL WALLENBERG STREET, TOWER A
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			6971916

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SciSparc Ltd./ADR
		DATE OF NAME CHANGE:	20210129

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Therapix Biosciences Ltd.
		DATE OF NAME CHANGE:	20140624
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>ea0243053-6k_scisparc.htm
<DESCRIPTION>REPORT OF FOREIGN PRIVATE ISSUER
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">UNITED STATES</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">SECURITIES AND EXCHANGE COMMISSION</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Washington, D.C. 20549</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Form 6-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Report of Foreign Private Issuer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Pursuant to Rule 13a-16 or 15d-16</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Under the Securities Exchange Act of 1934</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">For the month of: May 2025 (Report No. 2)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Commission file number: 001-38041</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><U>SCISPARC LTD.</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Translation of registrant&rsquo;s name into English)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>20 Raul Wallenberg Street,
Tower A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><U>Tel Aviv 6971916,
Israel</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Address of principal executive offices)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Form 20-F <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9746;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Form
40-F <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B><U>CONTENTS</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in">Attached hereto and incorporated
by reference herein is the Notice of Annual General Meeting of Shareholders, Proxy Statement and Proxy Card for the Annual General Meeting
of Shareholders of SciSparc Ltd. (the &ldquo;<B>Company</B>&rdquo;) to be held on Wednesday, June 25, 2025 (the &ldquo;<B>Meeting</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Only shareholders of record
who hold ordinary shares, no par value, of the Company at the close of business on Tuesday, May 27, 2025, will be entitled to notice of
and to vote at the Meeting and any postponements or adjournments thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This Report of Foreign Private Issuer on Form
6-K and its exhibits, are incorporated by reference into the Company&rsquo;s registration statements on Form F-3 (File Nos. <A HREF="http://www.sec.gov/Archives/edgar/data/1611746/000101376225002218/ea0235372-f3_scisparc.htm">333-286099</A>,
<A HREF="http://www.sec.gov/Archives/edgar/data/1611746/000121390023083494/ea187529-f3_scisparc.htm">333-275305</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1611746/000121390023012516/ea172999-f3_scisparc.htm">333-269839</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1611746/000121390022037966/ea162219-f3_scisparcltd.htm">333-266047</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1611746/000121390019016523/ff32019_therapixbio.htm">333-233417</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1611746/000121390022022376/ea158932-posam_scisparcltd.htm">333-248670</A> and <A HREF="http://www.sec.gov/Archives/edgar/data/1611746/000121390023018886/ea174796-posam_scisparc.htm">333-255408</A>) and on Form S-8 (File Nos. <A HREF="http://www.sec.gov/Archives/edgar/data/1611746/000121390025035801/ea0239224-s8_scisparc.htm">333-286791</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1611746/000121390024028880/ea0203015-s8_scisparc.htm">333-278437</A> and <A HREF="http://www.sec.gov/Archives/edgar/data/1611746/000121390018008005/fs82018_therapixbiosciences.htm">333-225773</A>)
filed with the Securities and Exchange Commission to be a part thereof from the date on which this report is submitted, to the extent
not superseded by documents or reports subsequently filed or furnished.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.45in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 9%"><FONT STYLE="font-size: 10pt"><B>Exhibits&nbsp;No.</B>&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 90%; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 10pt">99.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><A HREF="ea024305301ex99-1_scisparc.htm">Notice and Proxy Statement for the Annual General Meeting to be held on June 25, 2025.</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 10pt">99.2</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><A HREF="ea024305301ex99-2_scisparc.htm">Proxy Card for the Annual General Meeting to be held on June 25, 2025.</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>SIGNATURES</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 10pt"><U>SciSparc Ltd.</U></FONT></TD>
    </TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 60%"><FONT STYLE="font-size: 10pt">Date: May 21, 2025</FONT></TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-size: 10pt">By</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 35%"><FONT STYLE="font-size: 10pt">/s/ <I>Oz Adler</I></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Oz Adler</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Chief Executive Officer and Chief Financial Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">2</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ea024305301ex99-1_scisparc.htm
<DESCRIPTION>NOTICE AND PROXY STATEMENT FOR THE ANNUAL GENERAL MEETING TO BE HELD ON JUNE 25, 2025
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&nbsp;</P>

<P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: center"><IMG SRC="ex99-1_001.jpg" ALT=""></P>

<P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right; text-indent: 0.5in">May 21, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B>Dear SciSparc Ltd. Shareholders:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">We cordially invite
you to attend the Annual General Meeting of Shareholders of SciSparc Ltd. (the &ldquo;<B><I>Meeting</I></B>&rdquo;), to be held on Wednesday,
June 25, 2025 at 3:00&nbsp;p.m. (Israel time), at the Company&rsquo;s offices, at 20 Raul Wallenberg Street, Tower A, Tel Aviv 6971916
Israel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">At the Meeting, shareholders
will be asked to consider and vote on the matters listed in the enclosed Notice of Annual General Meeting of Shareholders (the &ldquo;<B><I>Notice</I></B>&rdquo;).
Our board of directors recommends that you vote <B>FOR</B> each of the proposals listed in the Notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Only shareholders
of record at the close of business on Tuesday, May 27, 2025 are entitled to notice of and to vote at the Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Whether or not you
plan to attend the Meeting, it is important that your ordinary shares be represented and voted at the Meeting. Accordingly, after reading
the enclosed Notice and the accompanying proxy statement, please sign, date and mail the enclosed proxy card in the envelope provided
or vote by telephone or over the Internet in accordance with the instructions on your proxy card.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">We look forward to
greeting as many of you as can attend the Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 40%; text-align: justify"><FONT STYLE="font-size: 10pt">Sincerely,</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Mr.&nbsp;Amitay Weiss</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><I>Chairman of the Board of Directors</I></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><IMG SRC="ex99-1_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><B>Notice of Annual General Meeting of
Shareholders</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><B>To be Held on June 25, 2025</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B>Dear SciSparc Ltd. Shareholders:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">We cordially invite
you to attend the Annual General Meeting of Shareholders (the &ldquo;<B><I>Meeting</I></B>&rdquo;) of SciSparc Ltd. (the &ldquo;<B><I>Company</I></B>&rdquo;),
to be held on Wednesday, June 25, 2025 at 3:00 p.m. (Israel time), at the Company&rsquo;s offices, at 20 Raul Wallenberg Street, Tower
A, Tel Aviv 6971916 Israel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">The following matters
(the &ldquo;<B><I>Proposals</I></B>&rdquo;) are on the agenda for the Meeting:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">to re-elect each of Mr. Alon Dayan, Mr. Moshe Revach and Mr. Lior Vider to serve as Class II directors
of the Company, until the Company&rsquo;s third annual general meeting of shareholders following this Meeting, and until their respective
successor is duly elected and qualified;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">to approve an increase to the Company&rsquo;s authorized share capital and to amend the Company&rsquo;s
amended and restated articles of association accordingly;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">to approve a reverse split of the Company&rsquo;s issued and outstanding ordinary shares in the range
of a ratio between 1:2 and 1:250, to be effected at the discretion of, at such ratio within the range and by such number of increments,
and on such dates, as may be determined by the Company&rsquo;s board of directors within 18 months following the date of the Meeting;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(iv)</TD><TD STYLE="text-align: justify">to approve the re-adoption of the compensation policy for the Company&rsquo;s executive officers and directors;
and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(v)</TD><TD STYLE="text-align: justify">to re-appoint Kost, Forer, Gabbay &amp; Kasierer, a member of Ernst &amp; Young Global, as the Company&rsquo;s
independent registered public accounting firm for the year ending December 31, 2025 and until the next annual general meeting of shareholders,
and to authorize the Company&rsquo;s board of directors (with power of delegation to its audit committee) to set the fees to be paid to
such auditors.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">In addition to considering
the foregoing Proposals, the Company&rsquo;s shareholders will have the opportunity to hear from representatives of the Company&rsquo;s
management, who will be available at the Meeting to review and discuss with shareholders the consolidated financial statements of the
Company for the year ended December&nbsp;31, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">You are entitled to
receive notice of, and vote at, the Meeting if you are a shareholder of record at the close of business on Tuesday ,May 27, 2025, in person
or through a broker, trustee or other nominee that is one of our shareholders of record at such time, or which appear in the participant
listing of a securities depository on that date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">You can vote your
ordinary shares by attending the Meeting or by completing and signing the proxy card to be distributed with the proxy statement. If you
hold ordinary shares through a bank, broker or other nominee (i.e., in &ldquo;street name&rdquo;) which is one of our shareholders of
record at the close of business on Tuesday, May 27, 2025, or which appears in the participant listing of a securities depository on that
date, you must follow the instructions included in the voting instruction form you receive from your bank, broker or nominee, and may
also be able to submit voting instructions to your bank, broker or nominee by phone or via the Internet. Please be certain to have your
control number from your voting instruction form ready for use in providing your voting instructions. If you hold your ordinary shares
in &ldquo;street name,&rdquo; you must obtain a legal proxy from the record holder to enable you to participate in and to vote your ordinary
shares at the Meeting (or to appoint a proxy to do so).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><B><I></I></B></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><B><I>Our board of
directors recommends that you vote FOR each of the above Proposals, which are described in the proxy statement.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">The presence (in person
or by proxy) of any two or more shareholders holding, in the aggregate, at least 15% of the voting power of the Company&rsquo;s ordinary
shares constitutes a quorum for purposes of the Meeting. If such quorum is not present within half an hour from the time scheduled for
the Meeting, the Meeting will be adjourned to Thursday, June 26, 2025, at 3:00 p.m. (Israel time). At such adjourned meeting the presence
of at least one or more shareholders in person or by proxy (regardless of the voting power represented by their ordinary shares) will
constitute a quorum.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">The last date for
submitting a request to include a proposal in accordance with Section&nbsp;66(b)&nbsp;of the Israeli Companies Law,&nbsp;5759-1999, is
Wednesday, May 28, 2025. A copy of the proxy statement (which includes the full version of the proposed resolutions) and a proxy card
is being made available to shareholders and also furnished to the U.S.&nbsp;Securities and Exchange Commission, pursuant to a Report of
Foreign Private Issuer on Form&nbsp;6-K.&nbsp;Shareholders are also able to review the proxy statement at the &ldquo;<I>Investors</I>&rdquo;
portion of the Company&rsquo;s website, <I>https://investor.scisparc.com/</I> or at its offices at 20 Raul Wallenberg Street, Tower A
Tel Aviv 6971916 Israel, upon prior notice and during regular working&nbsp;hours (telephone number: +972-3-7175777) until the date of
the Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Whether or not you
plan to attend the Meeting, it is important that your ordinary shares be represented and voted at the Meeting. Accordingly, after reading
the Notice of Annual General Meeting of Shareholders and the proxy statement, please sign, date and mail the proxy card in the envelope
provided or vote by telephone or over the Internet in accordance with the instructions on your proxy card. If voting by mail, the proxy
card must be received by no later than 11:59&nbsp;p.m. EDT, Tuesday, June 24, 2025 to be validly included in the tally of ordinary shares
voted at the Meeting. Detailed proxy voting instructions will be provided both in the proxy statement and in the proxy card.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 40%; text-align: justify"><FONT STYLE="font-size: 10pt">By Order of the Board of Directors,</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Mr.&nbsp;Amitay Weiss</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><I>Chairman of the Board of Directors</I></FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><B>&nbsp;</B></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex99-1_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><B>Proxy Statement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><B>Annual General Meeting of Shareholders<BR>
To Be Held on June 25, 2025</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">This proxy statement
is being furnished in connection with the solicitation of proxies on behalf of the board of directors (the &ldquo;<B><I>Board</I></B>&rdquo;)
of SciSparc Ltd. (the &ldquo;<B><I>Company</I></B><I>,</I>&rdquo; &ldquo;<B><I>SciSparc,</I></B>&rdquo; &ldquo;<B><I>we</I></B>,&rdquo;
&ldquo;<B><I>our</I></B>&rdquo; or &ldquo;<B><I>us</I></B>&rdquo;) to be voted at an Annual General Meeting of Shareholders (the &ldquo;<B><I>Meeting</I></B>&rdquo;),
and at any adjournment or postponement thereof, pursuant to the accompanying Notice of Annual General Meeting of Shareholders (the &ldquo;<B><I>Notice</I></B>&rdquo;).
The Meeting will be held on Wednesday, June 25, 2025, at 3:00 p.m. (Israel time), at the Company&rsquo;s offices, at 20 Raul Wallenberg
Street, Tower A, Tel Aviv 6971916 Israel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">This proxy statement,
the attached Notice and the enclosed proxy card or voting instruction form are being made available to holders of SciSparc&rsquo;s ordinary
shares, beginning May 21, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">You are entitled to
receive notice of, and vote at, the Meeting if you are a shareholder of record at the close of business on Tuesday, May 27, 2025, in person
or through a broker, trustee or other nominee that is one of our shareholders of record at such time, or which appear in the participant
listing of a securities depository on that date. You can vote your ordinary shares by attending the Meeting or by following the instructions
under &ldquo;<I>How You Can Vote</I>&rdquo; below. Our Board urges you to vote your ordinary shares so that they will be counted at the
Meeting or at any postponements or adjournments of the Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>Agenda Items</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">The following matters
(the &ldquo;<B><I>Proposals</I></B>&rdquo;) are on the agenda for the Meeting:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -20.25pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(1)</TD><TD STYLE="text-align: justify">to re-elect each Mr. Alon Dayan, Mr. Moshe Revach and Mr. Lior Vider to serve as Class II directors of
the Company, to serve until the Company&rsquo;s third annual general meeting of shareholders following this Meeting, and until their respective
successor is duly elected and qualified;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -20.25pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(2)</TD><TD STYLE="text-align: justify">to approve an increase to the Company&rsquo;s authorized share capital and to amend the Company&rsquo;s
amended and restated articles of association accordingly;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -20.25pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(3)</TD><TD STYLE="text-align: justify">to approve a reverse split of the Company&rsquo;s issued and outstanding ordinary shares in the range
of a ratio between 1:2 and 1:250, to be effected at the discretion of, at such ratio within the range and by such number of increments,
and on such dates, as may be determined by the Board within 18 months following the date of the Meeting;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -20.25pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(4)</TD><TD STYLE="text-align: justify">to approve the re-adoption of the compensation policy for the Company&rsquo;s executive officers and directors;
and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -20.25pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(5)</TD><TD STYLE="text-align: justify">to re-appoint Kost, Forer, Gabbay &amp; Kasierer, a member of Ernst &amp; Young Global, as our independent
registered public accounting firm for the year ending December 31, 2025 and until the next annual general meeting of shareholders, and
to authorize the Company&rsquo;s Board (with power of delegation to its audit committee) to set the fees to be paid to such auditors.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">In addition to considering
the foregoing Proposals, the Company&rsquo;s shareholders will have the opportunity to hear from representatives of the Company&rsquo;s
management, who will be available at the Meeting to review and discuss with shareholders the consolidated financial statements of the
Company for the year ended December&nbsp;31, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">We are not aware of
any other matters that will come before the Meeting. If any other matters are presented properly at the Meeting, the persons designated
as proxies intend to vote upon such matters in accordance with their best judgment and the recommendation of the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>Board Recommendation</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><B>Our Board unanimously
recommends that you vote &ldquo;FOR&rdquo; each of the above Proposals.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>Quorum and Adjournment</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">As of May 20, 2025,
we had a total of 11,225,751 ordinary shares issued and outstanding. Each ordinary share outstanding as of the close of business on Tuesday,
May 27, 2025, is entitled to one vote on each of the Proposals to be presented at the Meeting. Under our amended and restated articles
of association, currently in effect (the &ldquo;<B><I>Articles</I></B>&rdquo;), the Meeting will be properly convened if at least two
shareholders attend the Meeting in person or sign and return proxies, provided that they hold ordinary shares representing at least 15%
of our voting power. If such quorum is not present within half an hour from the time scheduled for the Meeting, the Meeting will be adjourned
to Thursday, June 26, 2025 at 3:00 p.m. (Israel time). At such adjourned meeting the presence of at least one or more shareholders in
person or by proxy (regardless of the voting power represented by their ordinary shares) will constitute a quorum.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Abstentions and &ldquo;broker
non-votes&rdquo; are counted as present and entitled to vote for purposes of determining a quorum. A &ldquo;broker non-vote&rdquo; occurs
when a bank, broker or other holder of record holding ordinary shares for a beneficial owner attends the Meeting but does not vote on
a particular Proposal because that holder does not have discretionary voting power for that particular item and has not received instructions
from the beneficial owner. Brokers that hold ordinary shares in &ldquo;street name&rdquo; for clients (as described below) typically have
authority to vote on &ldquo;routine&rdquo; Proposals even when they have not received instructions from beneficial owners. The only item
on the Meeting agenda that may be considered routine is Proposal&nbsp;No. 5 relating to the reappointment of the Company&rsquo;s independent
registered public accounting firm until the next annual general meeting of shareholders; however, we cannot be certain whether this will
be treated as a routine matter since our proxy statement is prepared in compliance with the Israeli Companies Law,&nbsp;5759-1999 (the
&ldquo;<B><I>Companies Law</I></B>&rdquo;), rather than the rules applicable to domestic U.S.&nbsp;reporting companies. Therefore, it
is important for a shareholder that holds ordinary shares through a bank or broker to instruct its bank or broker how to vote its ordinary
shares, if the shareholder wants its ordinary shares to count for the Proposals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>Vote Required for Approval of Each
of the Proposals</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">The affirmative vote
of the holders of a majority of the voting power represented and voting in person or by proxy is required to approve each of the Proposals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">In addition, approval
of Proposal No. 4 is subject to the fulfillment of one of the following additional voting requirements: (i) the majority of the ordinary
shares that are voted at the Meeting in favor of the Proposal, excluding abstentions, includes a majority of the votes of shareholders
who are neither controlling shareholders nor have a personal interest in the approval of the Proposal (each, an &ldquo;<B><I>Interested
Shareholder</I></B>&rdquo;); or (ii) the total percentage of ordinary shares of the shareholders mentioned in clause (i) above that are
voted against the Proposal does not exceed two percent (2%) of the total voting rights in the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">For this purpose,
a &ldquo;controlling shareholder&rdquo; is any shareholder that has the ability to direct the Company&rsquo;s activities (other than by
means of being a director or office holder of the Company). A person is presumed to be a controlling shareholder if it holds or controls,
by itself or together with others, one half or more of any one of the &ldquo;means of control&rdquo; of a company. &ldquo;Means of control&rdquo;
is defined as any one of the following: (i) the right to vote at a general meeting of a company, or (ii) the right to appoint directors
of a company or its chief executive officer. A &ldquo;personal interest&rdquo; of a shareholder in an action or transaction of a company
includes a personal interest of any of the shareholder&rsquo;s relatives (i.e. spouse, brother or sister, parent, grandparent, child as
well as child, brother, sister or parent of such shareholder&rsquo;s spouse or the spouse of any of the above) or an interest of a company
with respect to which the shareholder or the shareholder&rsquo;s relative (as defined above) holds 5% or more of such company&rsquo;s
issued shares or voting rights, in which any such person has the right to appoint a director or the chief executive officer or in which
any such person serves as director or the chief executive officer, including the personal interest of a person voting pursuant to a proxy
which the proxy grantor has a personal interest, whether or not the person voting pursuant to such proxy has discretion with regards to
the vote; and excludes an interest arising solely from the ownership of ordinary shares of a company. For the purpose of a holding, two
or more persons holding voting rights in the company each of which has a personal interest in the approval of the transaction being brought
for approval of the company will be considered to be joint holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Under Israeli law,
every voting shareholder is required to notify the Company whether such shareholder is an Interested Shareholder. To avoid confusion,
every shareholder voting by means of the enclosed proxy card or voting instruction form, or via telephone or internet voting, will be
deemed to confirm that such shareholder is NOT an Interested Shareholder. If you are an Interested Shareholder (in which case your vote
will only count for or against the ordinary majority, and not for or against the special tally under Proposal No. 4), please notify Mr.
Oz Adler, the Company&rsquo;s Chief Executive Officer, at 20 Raul Wallenberg Street, Tower A, Tel Aviv 6971916 Israel, telephone: +972-3-7175777,
or by email (oz@scisparc.com). If your shares are held in &ldquo;street name&rdquo; by your broker, bank or other nominee and you are
an Interested Shareholder, you should notify your broker, bank or other nominee of that status, and they in turn should notify the Company
as described in the preceding sentence.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">We do not believe
we have a controlling shareholder as of the record date of the Meeting, and therefore, we believe that (other than our executive officers,
directors and their relatives) none of our shareholders should have a personal interest in Proposal No. 4 and therefore should not be
deemed an Interested Shareholder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">In connection with
Proposal No. 4, the Companies Law allows the Board to approve such proposal even if the general meeting of shareholders has voted against
its approval, provided that the Company&rsquo;s compensation committee, and thereafter the Board, each determines to approve it, based
on detailed arguments, and after having reconsidered the matter and concluded that such action is in the best interest of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>How You Can Vote</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">You can vote either
in person at the Meeting or by authorizing another person as your proxy, whether or not you attend the Meeting. You may vote in any of
the manners below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><B><I>By Internet</I></B>&nbsp;&mdash;&nbsp;If you are a
shareholder of record, you can submit a proxy over the Internet by logging on to the website listed on the enclosed proxy card, entering
your control number located on the enclosed proxy card and submitting a proxy by following the on-screen prompts. If you hold shares
in &ldquo;street name,&rdquo; and if the brokerage firm, bank or other similar nominee that holds your shares offers Internet voting,
you may follow the instructions shown on the enclosed voting instruction form in order to submit your proxy over the Internet;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -24pt"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><B><I>By telephone</I></B>&nbsp;&mdash;&nbsp;If you are a
shareholder of record, you can submit a proxy by telephone by calling the toll-free number listed on the enclosed proxy card, entering
your control number located on the enclosed proxy card and following the prompts. If you hold shares in &ldquo;street name,&rdquo; and
if the brokerage firm, bank or other similar organization that holds your shares offers telephone voting, you may follow the instructions
shown on the enclosed voting instruction form in order to submit a proxy by telephone; or</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><B><I>By mail</I></B>&nbsp;&mdash;&nbsp;If you are a shareholder
of record and received a printed proxy card, you can submit a proxy by completing, dating, signing and returning your proxy card in the
postage-paid envelope provided. You should sign your name exactly as it appears on the enclosed proxy card. If you are signing in a representative
capacity (for example, as a guardian, executor, trustee, custodian, attorney or officer of a corporation), please indicate your name
and title or capacity. If you hold shares in &ldquo;street name,&rdquo; you have the right to direct your brokerage firm, bank or other
similar organization on how to vote your shares, and the brokerage firm, bank or other similar organization is required to vote your
shares in accordance with your instructions. To provide instructions to your brokerage firm, bank or other similar organization by mail,
please complete, date, sign and return your voting instruction form in the postage-paid envelope provided by your brokerage firm, bank
or other similar organization.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><I>Registered Holders</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">If you are a shareholder
of record whose ordinary shares are registered directly in your name with our transfer agent, Vstock Transfer LLC, you can vote your ordinary
shares by attending the Meeting or by completing and signing a proxy card. In such case, these proxy materials are being sent directly
to you. As the shareholder of record, you have the right to grant your voting proxy directly to the individuals listed as proxies on the
proxy card or to vote in person at the Meeting. Please follow the instructions on the proxy card. You may change your mind and cancel
your proxy card by sending us a written notice, by signing and returning a proxy card with a later date, or by voting in person or by
proxy at the Meeting. We will not be able to count a proxy card from a registered holder unless we receive it at our offices at 20 Raul
Wallenberg Street, Tower A Tel Aviv 6971916 Israel, or Broadridge Financial Solutions, Inc. receives it in the enclosed envelope no later
than 11:59&nbsp;p.m. EDT on Tuesday, June 24, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">If you provide specific
instructions (by marking a box) with regard to the Proposals, your ordinary shares will be voted as you instruct. If you sign and return
your proxy card or voting instruction form without giving specific instructions your ordinary shares will be voted in favor of each Proposal
in accordance with the recommendation of the Board. The persons named as proxies in the enclosed proxy card will vote in their discretion
on any other matters that properly come before the Meeting, including the authority to adjourn the Meeting pursuant to Article&nbsp;30
of the Articles.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><I>Beneficial Owners</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">If you are a beneficial
owner of the ordinary shares held in a brokerage account or by a trustee or nominee, these proxy materials are being forwarded to you
together with a voting instruction form by the broker, trustee or nominee or an agent hired by the broker, trustee or nominee. As a beneficial
owner, you have the right to direct your broker, trustee or nominee how to vote, and you are also invited to attend the Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Because a beneficial
owner is not a shareholder of record, you may not vote those ordinary shares directly at the Meeting unless you obtain a &ldquo;legal
proxy&rdquo; from the broker, trustee or nominee that holds your ordinary shares, giving you the right to vote the ordinary shares at
the Meeting. Your broker, trustee or nominee has enclosed or provided voting instructions for you to use in directing the broker, trustee
or nominee how to vote your ordinary shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>Who Can Vote</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">You are entitled to
receive notice of, and vote at, the Meeting if you are a shareholder of record at the close of business on Tuesday, May 27, 2025, in person
or through a broker, trustee or other nominee that is one of our shareholders of record at such time, or which appear in the participant
listing of a securities depository on that date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>Revocation of Proxies</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Shareholders of record
may revoke the authority granted by their execution of proxies at any time before the effective exercise thereof by filing with us a written
notice of revocation or duly executed proxy bearing a later date, or by voting in person at the Meeting. A shareholder who holds shares
in &ldquo;street name&rdquo; should follow the directions of, or contact, the bank, broker or nominee if he, she or it desires to revoke
or modify previously submitted voting instructions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>Solicitation of Proxies</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Proxies are being
made available to shareholders beginning May 21, 2025. Certain officers, directors, employees and agents of SciSparc may solicit proxies
by telephone, emails, or other personal contact. We will bear the cost for the solicitation of the proxies, including postage, printing,
and handling, and will reimburse the reasonable expenses of brokerage firms and others for forwarding material to beneficial owners of
ordinary shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>Voting Results</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">The final voting results
will be tallied by the Company based on the information provided by Broadridge Financial Solutions, Inc. or otherwise, and the overall
results of the Meeting will be published following the Meeting on a Report of Foreign Private Issuer on Form&nbsp;6-K that will be furnished
to the U.S.&nbsp;Securities and Exchange Commission (the &ldquo;<B><I>SEC</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>Availability of Proxy Materials</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Copies of the proxy
card, the Notice and this proxy statement are available at the SEC&rsquo;s website at <I>www.sec.gov</I> and at the <I>Investors</I> section
of our website, <I>https://investor.scisparc.com/</I>. The contents of that website are not a part of this proxy statement. In addition,
shareholders of record who wish to receive by post-mail copies of the proxy materials, may contact the Company directly at 20 Raul Wallenberg
Street, Tower A, Tel Aviv 6971916 Israel, Attn: Oz Adler, Chief Executive Officer, telephone number: +972-3-7175777.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-variant: small-caps"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-variant: small-caps"><B>COMPENSATION
OF EXECUTIVE OFFICERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">For information concerning
the annual compensation earned during 2024 by our five most highly compensated executive officers see Item&nbsp;6.B. of our Annual Report
on Form&nbsp;20-F for the year ended December&nbsp;31, 2024, as filed with the SEC on April 24, 2025 (the &ldquo;<B><I>Annual Report</I></B>&rdquo;),
a copy of which is available on our website at <I>https://investor.scisparc.com</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-variant: small-caps"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-variant: small-caps"><B>DIRECTOR
INDEPENDENCE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Our Board has determined
that each of Mr.&nbsp;Ben Shay, Mr.&nbsp;Dayan, Mr. Revach, Ms. Sidi and Mr.&nbsp;Vider and satisfy the independent director requirements
under the Nasdaq Stock Market (&ldquo;<B><I>Nasdaq</I></B>&rdquo;) corporate governance requirements. As such, the Board is comprised
of a majority of independent directors as such term is defined in Nasdaq rules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Our Board has further
determined that each member of our audit committee is independent as such term is defined in Rule&nbsp;10A-3 under the Securities Exchange&nbsp;Act&nbsp;of&nbsp;1934,
as amended (the &ldquo;<B><I>Exchange&nbsp;Act</I></B>&rdquo;), and that each member of our audit committee and compensation committee
satisfies the additional requirements applicable under Nasdaq rules to members of audit committees and compensation committees, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><B>PROPOSAL&nbsp;1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><B>APPROVAL OF THE RE-ELECTION OF EACH OF MR. ALON DAYAN, MR. MOSHE REVACH AND <BR>
MR.&nbsp;LIOR VIDER AS A CLASS II DIRECTOR OF THE COMPANY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>Background</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Our Board currently
has seven directors, who are divided into three classes with staggered three-year terms as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">the Class&nbsp;I directors consist of Ms. Liat Sidi and Mr.&nbsp;Amnon
Ben Shay and their terms will expire at our annual general meeting of shareholders to be held in 2027;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">the Class&nbsp;II directors consist of Mr.&nbsp;Lior Vider,
Mr.&nbsp;Alon Dayan and Mr. Moshe Revach and their terms expire at the Meeting; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">the Class&nbsp;III directors consist of Mr.&nbsp;Amitay Weiss
and Mr.&nbsp;Itschak Shrem and their terms will expire at our annual general meeting of shareholders to be held in 2026.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">At each annual general
meeting of our shareholders, the election or re-election of directors following the expiration of the term of office of the directors
of that class, will be for a term of office that expires on the date of the third annual general meeting following such election or re-election.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">At the Meeting, shareholders
will be asked to re-elect each of Mr. Alon Dayan, Mr. Moshe Revach and Mr. Lior Vider as a director of the Company. Each of Mr. Dayan,
Mr. Revach and Mr. Vider qualifies as an independent director under the Nasdaq corporate governance rules. Mr. Dayan and Mr. Vider serve
as members of our audit committee, as well as members of our compensation committee. Each of Mr. Dayan and Mr. Vider also qualifies as
an independent director under the additional independence requirements of the rules of the SEC and of Nasdaq relating to audit committee
membership and compensation committee membership.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">If re-elected at the
Meeting, each of Mr. Alon Dayan, Mr. Moshe Revach and Mr. Lior Vider will serve until the third annual general meeting of our shareholders
following this Meeting, and until their respective successors have been duly elected and qualified, or until their office is vacated in
accordance with the Articles.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">In accordance with
the Companies Law, each of Mr. Alon Dayan, Mr. Moshe Revach and Mr. Lior Vider has certified to us that they meet all the requirements
of the Companies Law for election as a director of a public company and possess the necessary qualifications and has sufficient time to
fulfill their duties as a director of SciSparc, taking into account the special needs of SciSparc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">For information on
the compensation payable to our directors, please see Item&nbsp;6.B. of our Annual Report.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Biographical information
concerning Mr. Alon Dayan, Mr. Moshe Revach and Mr. Lior Vider is set forth below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><I>Mr. Alon Dayan</I>
has served as a member of our Board since January 2021 and served as our external director under the Companies Law between January 2021
and January 2022. Mr. Dayan is the founder of L1-Systems Ltd. and has served as its chief executive officer since 2014 and is also the
founder of Viewbix Inc. (formerly known as Virtual Crypto Technologies Inc.) (OTC: VBIX), a company he served as chief executive officer
from 2018 to 2019. Mr. Dayan is currently director at Viewbix Inc. Prior to that, he served as a business development manager at Elbit
Systems Ltd. from 2006 to 2013. Mr. Dayan holds a B.A. in electronical engineering from Ariel University, Israel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><I></I></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><I>Mr.&nbsp;Moshe
Revach</I>&nbsp;has served as a member of our Board since September 2022. Mr. Revach also previously served as our director since August&nbsp;2020
until his resignation on March&nbsp;13, 2022. Mr.&nbsp;Revach has served as vice-counselor of the Ramat Gan municipality and has been
on its financial committee since March 2024. Mr.&nbsp;Revach serves as a director of L.L.N IT solutions, a wholly owned&nbsp;subsidiary
of the Jewish Agency for Israel, RPG Economic Society, ParaZero Technologies Ltd. (Nasdaq: PRZO), Plantify Foods Inc (CVE: PTFY), and
Jeffs&rsquo; Brands Ltd (Nasdaq: JFBR). Mr.&nbsp;Revach previously served as a director of Biomedico Hadarim, and Jewish Experience Company
on behalf of the Jewish Agency and also served as deputy mayor of Ramat Gan, Israel from 2013 to 2023, while also heading the sports and
government relations departments in the Ramat Gan municipality. Mr.&nbsp;Revach holds an LL.B from the Ono Academic College, Israel, and
a B.A. in management and economics from the University of Derby.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><I>Mr. Lior Vider</I> has served
as a member of our Board since August 2020. Mr. Vider has served as investment manager at Finessa Capital since November 2023. Mr. Vider
previously served as chief investment manager for Impact Investment Management Ltd., from the Union Bank group, from 2007 to 2010 and
as chairman of the board of directors and a member of the group&rsquo;s investment committee of Rahkia Capital Markets Ltd. from 2006
to 2007. Mr. Vider also served as a director at Endymed Medical Ltd. and Apollo Power Ltd. Mr. Vider founded and managed sponser.co.il,
a financial portal specializing in services for investors from 2005 to 2017. Mr. Vider holds a B.A. in industry and management engineering
from Shenkar College in Israel.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>Proposal</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">It is proposed that
the following resolutions be adopted at the Meeting:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>RESOLVED</B>,
that Mr. Alon Dayan be re-elected as a Class&nbsp;II director, to serve until the third annual general meeting of shareholders following
this Meeting and until his successor has been duly elected and qualified, or until his office is vacated in accordance with the Articles
or the Companies Law;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><B>RESOLVED</B>, that
Mr. Moshe Revach be re-elected as a Class&nbsp;II director, to serve until the third annual general meeting of shareholders following
this Meeting and until his successor has been duly elected and qualified, or until his office is vacated in accordance with the Articles
or the Companies Law; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><B>RESOLVED</B>, that
Mr. Lior Vider be re-elected as a Class&nbsp;II director, to serve until the third annual general meeting of shareholders following this
Meeting and until his successor has been duly elected and qualified, or until his office is vacated in accordance with the Articles or
the Companies Law.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>Vote Required</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><I>See &ldquo;Vote Required for Approval
of Each of the Proposals&rdquo; above.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>Board Recommendation</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><B>The Board recommends
a vote &ldquo;FOR&rdquo; the re-election of each of Mr. Alon Dayan, Mr. Moshe Revach and Mr. Lior Vider as a Class&nbsp;II director for
a term to expire at the third annual general meeting of shareholders following this Meeting</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><B>PROPOSAL 2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><B>APPROVAL OF AN INCREASE TO THE COMPANY&rsquo;S AUTHORIZED
SHARE CAPITAL AND <BR>
TO AMEND THE ARTICLES OF ASSOCIATION ACCORDINGLY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><B>&nbsp;</B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Under the Articles,
our authorized share capital consists of 75,000,000 ordinary shares. At the Meeting, shareholders will be asked to approve an increase
to the Company&rsquo;s authorized share capital to 2,000,000,000 (two billion) ordinary shares, and to approve to amend the Articles accordingly.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Our Board has determined
that it is in the best interests of the Company and our shareholders to increase the authorized share capital of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">On April 10, 2024, the Company
entered into an agreement and plan of merger (the &ldquo;<B><I>Merger Agreement</I></B>&rdquo;) by and among the Company, AutoMax Motors
Ltd. (&ldquo;<B><I>AutoMax</I></B>&rdquo;), and SciSparc Merger Sub Ltd., a wholly-owned subsidiary of the Company (&ldquo;<B><I>Merger
Sub</I></B>&rdquo;). Upon the terms and subject to the satisfaction of the conditions described in the Merger Agreement, including approval
of the transaction by the Company&rsquo;s shareholders and AutoMax&rsquo;s shareholders, Merger Sub will be merged with and into AutoMax,
with AutoMax surviving the Merger as a wholly-owned subsidiary of the Company (the &ldquo;<B><I>Merger</I></B>&rdquo;). At the effective
time of the Merger each outstanding share of AutoMax&rsquo;s share capital will be converted into the right to receive ordinary shares
of the Company, in accordance with the exchange ratio described in the Merger Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">The increase in the
authorized share capital of the Company is designed to enable us to have sufficient authorized share capital that can be issued at the
effective time of the Merger and to allow us to meet our future business needs as they arise. These needs could include, among other things,
the sale of shares in public and private offerings to raise additional capital, the acquisition of other companies, the use of shares
for various equity compensation and other employee benefit plans and arrangements and other bona fide corporate purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">If approved at the
Meeting, Section 5(a) of the Articles will be amended to read as follows (additions are bold and underlined, and deletions are struck
through):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&ldquo;5. (a) The authorized share capital of
the Company shall consist of <STRIKE>75,000,000</STRIKE> <B><U>2,000,000,000</U></B> Ordinary Shares without par value (the &ldquo;<B>Shares</B>&rdquo;).&rdquo;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">No further changes to the Articles will be made pursuant to this Proposal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><B><I>Proposal</I></B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">It is proposed that
the following resolution be adopted at the Meeting:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>RESOLVED</B>,
to approve an increase to the Company&rsquo;s authorized share capital and to amend the Company&rsquo;s Articles accordingly, as set forth in
the Proxy Statement, dated May 21, 2025.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>Vote Required</I></B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><I>See &ldquo;Vote Required for Approval of Each of the Proposals&rdquo;
above.</I></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>Board Recommendation</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><B>The Board recommends a
vote &ldquo;FOR&rdquo; the approval of an increase to the Company&rsquo;s authorized share capital and to amend the Articles accordingly</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><B>PROPOSAL 3</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><B>APPROVAL OF A REVERSE SPLIT OF THE COMPANY&rsquo;S
ISSUED AND OUTSTANDING ORDINARY SHARES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><B><I>Background</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 35.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">On May 20, 2025, the Board
approved, subject to the approval of our shareholders, a framework for a reverse split of the issued and outstanding ordinary shares in
the range of a ratio of between 1:2 and 1:250, to be effected at the discretion of, at such ratio within the approved range and by such
number of increments, and on such dates, as may be determined by the Board within 18 months following the date of the Meeting (the &ldquo;<B><I>Reverse
Split</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">On July 16, 2024, the Company
received a written notice from Nasdaq indicating that it is not in compliance with the minimum bid price requirement for continued listing
set forth in Nasdaq Listing Rule 5550(a)(2), which requires listed securities to maintain a minimum bid price of $1.00 per share. Under
Nasdaq Listing Rule 5810(c)(3)(A), the Company was granted a period of 180 calendar days to regain compliance with the minimum bid price
requirement. On January 14, 2025, the Company received an additional written notice from Nasdaq indicating that it had been granted, per
its request, an additional 180-day compliance period, or until July 14, 2025, to regain compliance with the minimum bid price requirement.&nbsp;If
at any time during this period the closing bid price of our ordinary shares is at least $1.00 per share for a minimum of 10 consecutive
business days, Nasdaq will provide the Company with a written confirmation of compliance and the matter will be closed. Accordingly, the
primary intent of conducting the Reverse Split is to increase the share price of&nbsp;our ordinary shares to enable the Company to meet
the minimum bid price requirement of Nasdaq. On May 20, 2025, the closing price of our ordinary shares on the Nasdaq Capital Market was
$0.321.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">On January 17, 2025, the
SEC approved an amendment to Nasdaq Listing Rule 5810(c)(3)(A)(iv), according to which, an issuer is not eligible for any compliance period
to cure a deficiency under the minimum bid price requirement if it effected a reverse share split over the prior one-year period. Due
to this amendment, our Board has resolved to approve a framework which allows for the conduction of multiple reverse share splits, in
order to remain in compliance with the minimum bid price requirement for an elongated period of time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">The Company believes that
the Reverse Split is advisable, so that its ordinary shares may be more attractive to a broader range of investors and to maintain compliance
with the Nasdaq minimum bid price requirement for continued listing if the price of the Company&rsquo;s ordinary shares does not otherwise
increase. The Board believes that the anticipated increased share price resulting from the Reverse Split may generate additional interest
in trading the Company&rsquo;s ordinary shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">The Company is therefore
seeking for the approval of its shareholders to effect the Reverse Split, in one or more increments, such that, depending on the ratio,
every two ordinary shares and up to every two hundred and fifty ordinary shares shall be consolidated into one ordinary share. If Proposal
No. 3 is approved by the Company&rsquo;s shareholders, our Board will have the discretionary authority, within 18 months from the Meeting,
to determine whether to implement such Reverse Split, the number of increments, and the exact ratio and the effective date of each increment,
such that the maximum range of the Reverse Split shall remain 1:250.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">If the Reverse Split is
implemented, the number of the issued and outstanding ordinary shares would be reduced in accordance with the Reverse Split ratio. The
Reverse Split, if implemented, would not adjust the number of authorized ordinary shares under the Articles, which, as of the date hereof
consists of 75,000,000 ordinary shares, and if approved under Proposal No. 2, will consist of 2,000,000,000 ordinary shares. In addition,
if the Reverse Split is implemented, the exercise price and the number of ordinary shares issuable pursuant to outstanding options and
warrants will be proportionately adjusted pursuant to the terms of the respective options and warrants in connection with the Reverse
Split. Furthermore, upon completion of the Reverse Split, the number of ordinary shares available for issuance under our incentive plans
shall be appropriately adjusted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">No fractional shares will
be issued as a result of the Reverse Split. In accordance with the Articles, all fractional shares will be rounded to the nearest whole
ordinary share, such that only shareholders holding fractional consolidated shares of more than one half of one whole share shall be entitled
to receive one consolidated share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Upon the implementation
of the Reverse Split, we intend to treat ordinary shares held by shareholders through a bank, broker, custodian or other nominee in the
same manner as registered shareholders whose ordinary shares are registered in their names. Banks, brokers, custodians or other nominees
will be instructed to effect the Reverse Split for their beneficial holders holding our ordinary shares in street name. However, these
banks, brokers, custodians or other nominees may have different procedures than registered shareholders for processing the Reverse Split.
Shareholders who hold our ordinary shares with a bank, broker, custodian or other nominee and who have any questions in this regard are
encouraged to contact their banks, brokers, custodians or other nominees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt -0.5in; text-align: justify; text-indent: 0.5in"><B><I>Proposal</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">It is proposed that the
following resolution be adopted at the Meeting:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>RESOLVED</B>,
to approve a reverse split of the Company&rsquo;s issued and outstanding ordinary shares in the range of a ratio between 1:2 and 1:250,
to be effected at the discretion of, at such ratio within the range and by such number of increments, and on such dates, as may be determined
by the Board within 18 months following the date of the Meeting, as detailed in the Proxy Statement, dated May 21, 2025.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt -0.5in; text-align: justify; text-indent: 0.5in"><B><I>Vote Required</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">See &ldquo;<I>Vote Required
for Approval of Each of the Proposals</I>&rdquo; above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt -0.5in; text-align: justify; text-indent: 0.5in"><B><I>Board Recommendation</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><B>The Board recommends
a vote &ldquo;FOR&rdquo; the approval of the Reverse Split</B>.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><B>PROPOSAL 4</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><B>APPROVAL OF THE RE-ADOPTION OF THE COMPENSATION
POLICY <BR>
FOR THE COMPANY&rsquo;S EXECUTIVE OFFICERS AND DIRECTORS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><B><I>Background</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 35.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">At&nbsp;the Meeting, shareholders
will be asked to approve to re-adopt our compensation policy regarding the terms of office and employment of our executive officers and
directors. As required by the Companies Law, we have adopted a compensation policy regarding the terms of office and employment of our
executive officers and directors. Our previous compensation policy (the &ldquo;<B><I>Previous Compensation Policy</I></B>&rdquo;) became
effective on February 10, 2022, following its approval by our shareholders and expired on February 10, 2025, in accordance with the Companies
Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Pursuant to the Companies
Law, the compensation policy must be re-approved once every three years by the Board, after considering the recommendations of the compensation
committee, and by the Company&rsquo;s shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Following a review of our
Previous Compensation Policy by our Compensation Committee and Board, our Compensation Committee and the Board propose re-adopting
the compensation policy in the same form as our Previous Compensation Policy, and attached to this Proxy Statement
as&nbsp;<B><U>Annex A</U> </B>(the &ldquo;<B><I>Proposed Compensation Policy</I></B>&rdquo;)<B>.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">The Proposed Compensation
Policy, if approved by our shareholders, will become effective immediately following the Meeting, for a period of three years. If the
Proposed Compensation Policy is not approved by our shareholders, we will have no compensation policy in effect. To the extent not approved
by our shareholders at the Meeting, our Compensation Committee and Board may nonetheless approve the Proposed Compensation Policy, following
re-discussion of the matter and for specified reasons, provided such approval is in the best interests of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">The Proposed Compensation
Policy is intended to incentivize individual excellence to align the interests of our office holders with the Company&rsquo;s short and
long-term goals and performance, and as a result, with those of our shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt -0.5in; text-align: justify; text-indent: 0.5in"><B><I>Proposal</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">It is proposed that the
following resolution be adopted at the Meeting:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>RESOLVED</B>,
to approve to re-adopt the compensation policy for the Company&rsquo;s executive officers and directors, as detailed in the Proxy Statement,
dated May 21, 2025&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt -0.5in; text-align: justify; text-indent: 0.5in"><B><I>Vote Required</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">See &ldquo;<I>Vote Required
for Approval of Each of the Proposals</I>&rdquo; above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt -0.5in; text-align: justify; text-indent: 0.5in"><B><I>Board Recommendation</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><B>The Board recommends
a vote &ldquo;FOR&rdquo; the re-adoption of the compensation policy for the Company&rsquo;s executive officers and director</B>s.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 35.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 35.45pt"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 35.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><B>PROPOSAL&nbsp;5</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><B>RE-APPOINTMENT OF INDEPENDENT AUDITORS AND <BR>
AUTHORIZATION OF THE BOARD TO FIX THEIR REMUNERATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>Background</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Our audit committee
and Board have each approved the re-appointment of Kost Forer Gabbay &amp; Kasierer, a member of Ernst &amp; Young Global, as our independent
registered public accounting firm for the year ending December 31, 2025 and until the next annual general meeting of shareholders, subject
to the approval of our shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">For information regarding
the total compensation that was paid by the Company and its subsidiaries to its independent auditors, please see Item&nbsp;16C of our
Annual Report.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>Proposal</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">It is proposed that
the following resolution be adopted at the Meeting:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>RESOLVED</B>,
to re-appoint Kost, Forer, Gabbay &amp; Kasierer, a member of Ernst &amp; Young Global, as the Company&rsquo;s independent registered
public accounting firm for the year ending December 31, 2025 and until the next annual general meeting of shareholders, and to authorize
the Company&rsquo;s board of directors (with power of delegation to its audit committee) to set the fees to be paid to such auditors in
accordance with the volume and nature of their services.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>Vote Required</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">See &ldquo;<I>Vote
Required for Approval of Each of the Proposals</I>&rdquo; above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>Board Recommendation</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><B>The Board recommends
a vote &ldquo;FOR&rdquo; the approval of the re-appointment of Kost, Forer, Gabbay &amp; Kasierer, a member of Ernst &amp; Young Global,
as our independent registered public accounting firm for the year ending December 31, 2025 and until the next annual general meeting of
shareholders.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><BR>
</P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><B>PRESENTATION AND DISCUSSION OF AUDITED
CONSOLIDATED FINANCIAL STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">In addition to considering
the foregoing agenda items at the Meeting, we will also present our audited consolidated financial statements for the fiscal year ended
December&nbsp;31, 2024. A copy of the Annual Report, including the audited consolidated financial statements for the year ended December&nbsp;31,
2024, is available for viewing and downloading on the SEC&rsquo;s website at <I>www.sec.gov</I>, as well as on the <I>Investors</I> section
of our Company&rsquo;s website at <I>https://investor.scisparc.com</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><B>OTHER BUSINESS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">The Board is not aware
of any other matters that may be presented at the Meeting other than those described in this proxy statement. If any other matters do
properly come before the Meeting, including the authority to adjourn the Meeting pursuant to Article&nbsp;16 of the Articles, it is intended
that the persons named as proxies will vote, pursuant to their discretionary authority, according to their best judgment in the interest
of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><B>ADDITIONAL INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">The Annual Report,
filed with the SEC on April 24, 2025, is available for viewing and downloading on the SEC&rsquo;s website at <I>www.sec.gov</I> as well
as under the Investors section of the Company&rsquo;s website at <I>https://investor.scisparc.com/</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">The Company is subject
to the information reporting requirements of the Exchange&nbsp;Act applicable to foreign private issuers. The Company fulfills these requirements
by filing reports with the SEC.&nbsp;The Company&rsquo;s filings with the SEC are available to the public on the SEC&rsquo;s website at
<I>www.sec.gov</I>. As a foreign private issuer, the Company is exempt from the rules under the Exchange&nbsp;Act related to the furnishing
and content of proxy statements. The circulation of this proxy statement should not be taken as an admission that the Company is subject
to those proxy rules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="width: 40%; text-align: justify"><FONT STYLE="font-size: 10pt">By Order of the Board of Directors,</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Mr.&nbsp;Amitay Weiss</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><I>Chairman of the Board of Directors</I></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Dated: May 21, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><B>Annex A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>COMPENSATION POLICY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SCISPARC LTD.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Compensation Policy for Executive Officers and
Directors</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(As Adopted on [__], 2025)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>A.&nbsp;<U>Overview and Objectives</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">1.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><B>Introduction</B></FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.2pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">This document sets forth the Compensation
Policy for Executive Officers and Directors (this &ldquo;<B>Compensation Policy</B>&rdquo; or &ldquo;<B>Policy</B>&rdquo;) of SciSparc
Ltd. (&ldquo;<B>SciSparc</B>&rdquo; or the &ldquo;<B>Company</B>&rdquo;), in accordance with the requirements of the Companies Law, 5759-1999
and the regulations promulgated thereunder (the &ldquo;<B>Companies Law</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.2pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Compensation is a key component of
SciSparc&rsquo;s overall human capital strategy to attract, retain, reward, and motivate highly skilled individuals that will enhance
SciSparc&rsquo;s value and otherwise assist SciSparc to reach its business and financial long-term goals. Accordingly, the structure of
this Policy is established to tie the compensation of each officer to SciSparc&rsquo;s goals and performance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.2pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">For purposes of this Policy, &ldquo;Executive
Officers&rdquo; shall mean &ldquo;Office Holders&rdquo; as such term is defined in Section 1 of the Companies Law, excluding, unless otherwise
expressly indicated herein, SciSparc&rsquo;s directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.2pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">This policy is subject to applicable
law and is not intended, and should not be interpreted as limiting or derogating from, provisions of applicable law to the extent not
permitted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.2pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">This Policy shall apply to compensation
agreements and arrangements which will be approved after the date on which this Policy is adopted and shall serve as SciSparc&rsquo;s
Compensation Policy for three (3) years, commencing as of its adoption, unless amended earlier.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.2pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Compensation Committee and the
Board of Directors of SciSparc (the &ldquo;<B>Compensation Committee</B>&rdquo; and the &ldquo;<B>Board</B>&rdquo;, respectively) shall
review and reassess the adequacy of this Policy from time to time, as required by the Companies Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">2.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><B>Objectives</B></FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.2pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">SciSparc&rsquo;s objectives and goals
in setting this Policy are to attract, motivate and retain experienced and talented leaders who will contribute to SciSparc&rsquo;s success
and enhance shareholder value, while demonstrating professionalism in an achievement-oriented and merit-based culture that rewards long-term
excellence, and embedding and modeling SciSparc&rsquo;s core values as part of a motivated behavior. To that end, this Policy is designed,
among other things:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">2.1.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">To closely align the interests
of the Executive Officers with those of SciSparc&rsquo;s shareholders in order to enhance shareholder value;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">2.2.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">To align a significant portion
of the Executive Officers&rsquo; compensation with SciSparc&rsquo;s short and long-term goals and performance;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">2.3.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">To provide the Executive Officers
with a structured compensation package, including competitive salaries, performance-motivating cash and equity incentive programs and
benefits, and to be able to present to each Executive Officer an opportunity to advance in a growing organization;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">2.4.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">To strengthen the retention
and the motivation of Executive Officers in the long-term;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">2.5.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">To provide appropriate awards
in order to incentivize superior individual excellence and corporate performance; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">2.6.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">To maintain consistency in
the way Executive Officers are compensated.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 17; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">3.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><B>Compensation Instruments</B></FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 17.85pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">Compensation instruments
under this Policy may include the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">3.1.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Base salary;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">3.2.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Benefits;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">3.3.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Cash bonuses;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">3.4.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Equity based compensation;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">3.5.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Change of control provisions;
and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">3.6.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Retirement and termination
terms.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">4.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><B>Overall Compensation - Ratio
Between Fixed and Variable Compensation</B></FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">4.1.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">This Policy aims to balance
the mix of &ldquo;Fixed Compensation&rdquo; (comprised of base salary and benefits) and &ldquo;Variable Compensation&rdquo; (comprised
of cash bonuses and equity-based compensation) in order to, among other things, appropriately incentivize Executive Officers to meet
SciSparc&rsquo;s short and long-term goals while taking into consideration the Company&rsquo;s need to manage a variety of business risks.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">4.2.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The total annual target bonus
and equity-based compensation per vesting annum (based on the fair market value at the time of grant calculated on a linear basis) of
each Executive Officer shall not exceed 95% of such Executive Officer&rsquo;s total compensation package for such year.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">5.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><B>Inter-Company Compensation
Ratio</B></FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">5.1.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">In the process of drafting
this Policy, SciSparc&rsquo;s Board and Compensation Committee have examined the ratio between employer cost associated with the engagement
of the Executive Officers, including directors, and the average and median employer cost associated with the engagement of SciSparc&rsquo;s
other employees (including contractor employees as defined in the Companies Law) (the &ldquo;<B>Ratio</B>&rdquo;).</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">5.2.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The possible ramifications
of the Ratio on the daily working environment in SciSparc were examined and will continue to be examined by SciSparc from time to time
in order to ensure that levels of executive compensation, as compared to the overall workforce will not have a negative impact on work
relations in SciSparc.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>B.&nbsp;<U>Base Salary and Benefits</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">6.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><B>Base Salary</B></FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">6.1.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">A base salary provides stable
compensation to Executive Officers and allows SciSparc to attract and retain competent executive talent and maintain a stable management
team. The base salary varies among Executive Officers, and is individually determined according to the educational background, prior
vocational experience, qualifications, corporate role, business responsibilities and past performance of each Executive Officer.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">6.2.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Since a competitive base salary
is essential to SciSparc&rsquo;s ability to attract and retain highly skilled professionals, SciSparc will seek to establish a base salary
that is competitive with base salaries paid to Executive Officers in a peer group of other companies operating in technology sectors
that are as much as possible similar in their characteristics to SciSparc. To that end, SciSparc shall utilize comparative market data
and practices as a reference, including a survey comparing and analyzing the level of the overall compensation package offered to an
Executive Officer of the Company with compensation packages for persons serving in similar positions (to that of the relevant officer)
in the peer group. Such compensation survey may be conducted internally or through an external independent consultant.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">6.3.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The Compensation Committee
and the Board may periodically consider and approve base salary adjustments for Executive Officers. The main considerations for salary
adjustment will be similar to those used in initially determining the base salary, but may also include change of role or responsibilities,
recognition for professional achievements, regulatory or contractual requirements, budgetary constraints or market trends. The Compensation
Committee and the Board will also consider the previous and existing compensation arrangements of the Executive Officer whose base salary
is being considered for adjustment. Any limitation herein based on the annual base salary shall be calculated based on the monthly base
salary applicable at the time of consideration of the respective grant or benefit.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">7.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><B>Benefits</B></FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">7.1.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The following benefits may
be granted to the Executive Officers in order, among other things, to comply with legal requirements:</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">7.1.1.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Vacation days in accordance
with market practice;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">7.1.2.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Sick days in accordance with
market practice;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">7.1.3.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Convalescence pay according
to applicable law;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">7.1.4.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Monthly remuneration for a study
fund, as allowed by applicable law and with reference to SciSparc&rsquo;s practice and the practice in peer group companies (including
contributions on bonus payments);</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">7.1.5.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">SciSparc shall contribute on
behalf of the Executive Officer to an insurance policy or a pension fund, as allowed by applicable law and with reference to SciSparc&rsquo;s
policies and procedures and the practice in peer group companies (including contributions on bonus payments); and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">7.1.6.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">SciSparc shall contribute on
behalf of the Executive Officer towards work disability insurance, as allowed by applicable law and with reference to SciSparc&rsquo;s
policies and procedures and to the practice in peer group companies.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">7.2.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Non-Israeli Executive Officers
may receive other similar, comparable or customary benefits as applicable in the relevant jurisdiction in which they are employed. Such
customary benefits shall be determined based on the methods described in Section &lrm;6.2 of this Policy (with the necessary changes
and adjustments).</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">7.3.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">In the events of relocation
and/or repatriation of an Executive Officer to another geography, such Executive Officer may receive other similar, comparable or customary
benefits as applicable in the relevant jurisdiction in which he or she is employed or additional payments to reflect adjustments in the
cost of living. Such benefits may include reimbursement for out-of-pocket one-time payments and other ongoing expenses, such as a housing
allowance, a car allowance, home leave visit, etc.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">7.4.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">SciSparc may offer additional
benefits to its Executive Officers, which will be comparable to customary market practices, such as, but not limited to: cellular and
land line phone benefits, company car and travel benefits, reimbursement of business travel including a daily stipend when traveling
and other business related expenses, insurances, other benefits (such as newspaper subscriptions, academic and professional studies),
etc., provided, however, that such additional benefits shall be determined in accordance with SciSparc&rsquo;s policies and procedures.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>C.&nbsp;<U>Cash Bonuses</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">8.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><B>Annual Cash Bonuses - The
Objective</B></FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">8.1.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Compensation in the form of
an annual cash bonus is an important element in aligning the Executive Officers&rsquo; compensation with SciSparc&rsquo;s objectives
and business goals. Therefore, annual cash bonuses will reflect a pay-for-performance element, with payout eligibility and levels determined
based on actual financial and operational results, in addition to other factors the Compensation Committee may determine, including individual
performance.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">8.2.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">An annual cash bonus may be
awarded to Executive Officers upon the attainment of pre-set periodical objectives and individual targets determined by the Compensation
Committee (and, if required by law, by the Board) for each fiscal year, or in connection with such officer&rsquo;s engagement, in case
of newly hired Executive Officers, taking into account SciSparc&rsquo;s short and long-term goals, as well as its compliance and risk
management policies. The Compensation Committee and the Board may also determine applicable minimum thresholds that must be met for entitlement
to the annual cash bonus (all or any portion thereof) and the formula for calculating any annual cash bonus payout, with respect to each
fiscal year, for each Executive Officer. In special circumstances, as determined by the Compensation Committee and the Board (e.g., regulatory
changes, significant changes in SciSparc&rsquo;s business environment, a significant organizational change, significant merger and acquisition
events, etc.), the Compensation Committee and the Board may modify the objectives and/or their relative weight during the fiscal year,
or may modify payouts following the conclusion of the year.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">8.3.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">In the event that the employment
of an Executive Officer is terminated prior to the end of a fiscal year, the Company may (but shall not be obligated to) pay such Executive
Officer an annual cash bonus (which may or may not be pro-rated) assuming the Executive Officer is otherwise entitled to an annual cash
bonus.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">8.4.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The actual annual cash bonus
to be paid to Executive Officers shall be approved by the Compensation Committee and the Board.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">9.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><B>Annual Cash Bonuses - The
Formula</B></FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 17.85pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><U>Executive Officers other
than the CEO</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 17.85pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">9.1.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The performance objectives
for the annual cash bonus of SciSparc&rsquo;s Executive Officers, other than the chief executive officer (the &ldquo;<B>CEO</B>&rdquo;),
may be approved by SciSparc&rsquo;s CEO (in lieu of the Compensation Committee) and may be based on company, division/ departmental/business
unit and individual objectives. Measurable performance objectives, which include the objectives and the weight to be assigned to each
achievement in the overall evaluation, may be based on actual financial and operational results, personal objectives, operational objectives,
project milestones objectives or investment in human capital objectives. The Company may also grant annual cash bonuses to SciSparc&rsquo;s
Executive Officers, other than the CEO, on a discretionary basis.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">9.2.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The target annual cash bonus
that an Executive Officer, other than the CEO, will be entitled to receive for any given fiscal year, will not exceed four (4) of such
Executive Officer&rsquo;s monthly base salaries.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">9.3.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The maximum annual cash bonus,
including for overachievement performance, that an Executive Officer, other than the CEO, will be entitled to receive for any given fiscal
year, will not exceed five (5) of such Executive Officer&rsquo;s monthly base salaries .</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17.85pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in; text-align: justify"><U>CEO</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17.85pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">9.4.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The annual cash bonus of SciSparc&rsquo;s
CEO will be based on measurable performance objectives and subject to minimum thresholds as provided in Section 8.2 above and based on
a discretionary element as provided in Section 9.5 below. Measurable performance objectives will be determined annually by SciSparc&rsquo;s
Compensation Committee (and, if required by law, by SciSparc&rsquo;s Board) and will be based on company and personal objectives.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">9.5.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The annual cash bonus granted
to SciSparc&rsquo;s CEO, may be based on a discretionary evaluation of the CEO&rsquo;s overall performance by the Compensation Committee
and the Board based on quantitative and qualitative criteria. The discretionary bonus for any given fiscal year will not exceed two (2)
of the CEO&rsquo;s monthly base salaries.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">9.6.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The target annual cash bonus
that the CEO will be entitled to receive for any given fiscal year, will not exceed six (6) of his or her monthly base salaries.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">9.7.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The maximum annual cash bonus
including for overachievement performance that the CEO will be entitled to receive for any given fiscal year, will not exceed eight (8)
of his or her monthly base salaries.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">10.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><B>Other Bonuses</B></FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">10.1.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Special Bonus</U>. SciSparc
may grant its Executive Officers a special bonus as an award for special achievements (such as in connection with mergers and acquisitions,
offerings, achieving target budget or business plan objectives under exceptional circumstances, or special recognition in case of retirement)
or as a retention award at the CEO&rsquo;s discretion for Executive Officers other than the CEO (and in the CEO&rsquo;s case, at the
Compensation Committee&rsquo;s and the Board&rsquo;s discretion), subject to any additional approval as may be required by the Companies
Law (the &ldquo;<B>Special Bonus</B>&rdquo;). Any such Special Bonus will not exceed 200% of the Executive Officer&rsquo;s annual base
salary. A Special Bonus can be paid, in whole or in part, in equity in lieu of cash and the value of any such equity component of a Special
Bonus shall be determined in accordance with Section &lrm;13.3 below.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">10.2.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Signing Bonus</U>. SciSparc
may grant a newly recruited Executive Officer a signing bonus. Any such signing bonus shall be granted and determined at the CEO&rsquo;s
discretion for Executive Officers other than the CEO (and in the CEO&rsquo;s case, at the Compensation Committee&rsquo;s and the Board&rsquo;s
discretion), subject to any additional approval as may be required by the Companies Law (the &ldquo;<B>Signing Bonus</B>&rdquo;). Any
such Signing Bonus will not exceed 100% of the Executive Officer&rsquo;s annual base salary.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">10.3.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Relocation/ Repatriation
Bonus</U>. SciSparc may grant its Executive Officers a special bonus in the event of relocation or repatriation of an Executive Officer
to another geography (the &ldquo;<B>Relocation Bonus</B>&rdquo;). Any such Relocation bonus will include customary benefits associated
with such relocation and its monetary value will not exceed 100% of the Executive Officer&rsquo;s annual base salary.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">11.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><B>Compensation Recovery (&ldquo;Clawback&rdquo;)</B></FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">11.1.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">In the event of an accounting
restatement, SciSparc shall be entitled to recover from its Executive Officers the bonus compensation or performance-based equity compensation
in the amount in which such compensation exceeded what would have been paid based on the financial statements, as restated, provided
that a claim is made by SciSparc prior to the second anniversary following the filing of such restated financial statements.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">11.2.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Notwithstanding the aforesaid,
the compensation recovery will not be triggered in the following events:</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">11.2.1.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The financial restatement is
required due to changes in the applicable financial reporting standards; or</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">11.2.2.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The Compensation Committee has
determined that Clawback proceedings in the specific case would be impossible, impractical, or not commercially or legally efficient.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">11.3.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Nothing in this Section &lrm;11
derogates from any other &ldquo;Clawback&rdquo; or similar provisions regarding disgorging of profits imposed on Executive Officers by
virtue of applicable securities laws or a separate contractual obligation.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>D.</B>&nbsp;<B><U>Equity Based Compensation</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">12.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><B>The Objective</B></FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">12.1.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The equity-based compensation
for SciSparc&rsquo;s Executive Officers will be designed in a manner consistent with the underlying objectives of the Company in determining
the base salary and the annual cash bonus, with its main objectives being to enhance the alignment between the Executive Officers&rsquo;
interests with the long-term interests of SciSparc and its shareholders, and to strengthen the retention and the motivation of Executive
Officers in the long term. In addition, since equity-based awards are structured to vest over several years, their incentive value to
recipients is aligned with longer-term strategic plans.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">12.2.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The equity-based compensation
offered by SciSparc is intended to be in the form of share options and/or other equity-based awards, such as restricted shares, RSUs
or performance stock units, in accordance with the Company&rsquo;s equity incentive plan in place as may be updated from time to time.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">12.3.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">All equity-based incentives
granted to Executive Officers (other than bonuses paid in equity in lieu of cash) shall normally be subject to vesting periods in order
to promote long-term retention of the awarded Executive Officers. Unless determined otherwise in a specific award agreement or in a specific
compensation plan approved by the Compensation Committee and the Board, grants to Executive Officers other than non-employee directors
shall vest based on time, gradually over a period of at least 2-4 years, or based on performance. The exercise price of options shall
be determined in accordance with SciSparc&rsquo;s policies, the main terms of which shall be disclosed in the annual report of SciSparc</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">12.4.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">All other terms of the equity
awards shall be in accordance with SciSparc&rsquo;s incentive plans and other related practices and policies. Accordingly, the Board
may, following approval by the Compensation Committee, make modifications to such awards consistent with the terms of such incentive
plans, subject to any additional approval as may be required by the Companies Law.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">13.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><B>General Guidelines for the
Grant of Awards</B></FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">13.1.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The equity-based compensation
shall be granted from time to time and be individually determined and awarded according to the performance, educational background, prior
business experience, qualifications, corporate role and the personal responsibilities of the Executive Officer.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">13.2.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">In determining the equity-based
compensation granted to each Executive Officer, the Compensation Committee and the Board shall consider the factors specified in Section
13.1 above, and in any event,&nbsp;<FONT STYLE="background-color: white">the total&nbsp;</FONT>fair market&nbsp;<FONT STYLE="background-color: white">value
of an annual equity-based compensation</FONT>&nbsp;award at the time of grant (not including bonuses paid in equity in lieu of cash)
shall not exceed: (i) with respect to the CEO - the higher of (w) 300% of his or her annual base salary or (x) 2% of the Company&rsquo;s
fair market value at the time of approval of the grant by the Board; and (ii) with respect to each of the other Executive Officers -
the higher of (y) 150% of his or her annual base salary or (z) 1% of the Company&rsquo;s fair market value at the time of approval of
the grant by the Board.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">13.3.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The fair market value of the
equity-based compensation for the Executive Officers will be determined by using the Black Scholes formula or according to other acceptable
valuation practices at the time of grant, in each case, as determined by the Compensation Committee and the Board.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>E.&nbsp;<U>Retirement and Termination of Service
Arrangements</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">14.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><B>Advanced Notice Period</B></FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">SciSparc may provide an Executive Officer,
on the basis of his/her seniority in the Company, his/her contribution to the Company&rsquo;s goals and achievements and the circumstances
of his/her retirement prior notice of termination of up to twelve (12) months in the case of the CEO and chairperson of the Board and
six (6) months in the case of other Executive Officers, during which the Executive Officer may be entitled to all of the compensation
elements, and to the continuation of vesting of his/her equity-based compensation. Such advance notice may or may not be provided in addition
to severance, provided, however, that the Compensation Committee shall take into consideration the Executive Officer&rsquo;s entitlement
to advance notice in establishing any entitlement to severance and vice versa.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">15.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><B>Adjustment Period</B></FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">SciSparc may provide an additional
adjustment period of up to six (6) months to the CEO or to any other Executive Officer according to his/her seniority in the Company,
his/her contribution to the Company&rsquo;s goals and achievements and the circumstances of retirement, during which the Executive Officer
may be entitled to all of the compensation elements, and to the continuation of vesting of his/her equity-based compensation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">16.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><B>Additional Retirement and
Termination Benefits</B></FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">SciSparc may provide additional retirement
and terminations benefits and payments as may be required by applicable law (e.g., mandatory severance pay under Israeli labor laws),
or which will be comparable to customary market practices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">17.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><B>Non-Compete Grant</B></FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Upon termination of employment and
subject to applicable law, SciSparc may grant to its Executive Officers a non-compete grant as an incentive to refrain from competing
with SciSparc for a defined period of time. The terms and conditions of the non-compete grant shall be decided by the Board and shall
not exceed such Executive Officer&rsquo;s monthly base salary multiplied by twelve (12). The Board shall consider the existing entitlements
of the Executive Officer in connection with the consideration of any non-compete grant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">18.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><B>Limitation Retirement and
Termination of Service Arrangements</B></FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The total non-statutory payments under
Section 14-17 above for a given Executive Officer shall not exceed the Executive Officer&rsquo;s monthly base salary multiplied by twenty-four
(24). The limitation under this Section 18 does not apply to benefits and payments provided under other chapters of this Policy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>F.&nbsp;<U>Exculpation, Indemnification and
Insurance</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">19.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><B>Exculpation</B></FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Each and every Director and Executive
Officer may be exempted in advance for all or any of his/her liability for damage in consequence of a breach of the duty of care, to the
fullest extent permitted by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">20.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><B>Insurance and Indemnification</B></FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">20.1.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">SciSparc may indemnify its
directors and Executive Officers to the fullest extent permitted by applicable law, for any liability and expense that may be imposed
on the director or the Executive Officer, as provided in the indemnity agreement between such individuals and SciSparc all subject to
applicable law and the Company&rsquo;s articles of association.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">20.2.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">SciSparc will provide directors&rsquo;
and officers&rsquo; liability insurance (the&nbsp;<B>&ldquo;Insurance Policy&rdquo;)&nbsp;</B>for its directors and Executive Officers
as follows:</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">20.2.1.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The limit of liability of the
insurer shall not exceed the greater of $50 million or 50% of the Company&rsquo;s shareholders equity based on the most recent financial
statements of the Company at the time of approval of the Insurance Policy by the Compensation Committee; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">20.2.2.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The Insurance Policy, as well
as the limit of liability and the premium for each extension or renewal shall be approved by the Compensation Committee (and, if required
by law, by the Board) which shall determine that the sums are reasonable considering SciSparc&rsquo;s exposures, the scope of coverage
and the market conditions and that the Insurance Policy reflects the current market conditions and that it shall not materially affect
the Company&rsquo;s profitability, assets or liabilities.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">20.3.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Upon circumstances to be approved
by the Compensation Committee (and, if required by law, by the Board), SciSparc shall be entitled to enter into a &ldquo;run off&rdquo;
Insurance Policy (the&nbsp;<B>&ldquo;Run-Off Policy&rdquo;)&nbsp;</B>of up to seven (7) years, with the same insurer or any other insurance,
as follows:</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">20.3.1.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The limit of liability of the
insurer shall not exceed the greater of $50 million or 50% of the Company&rsquo;s shareholders equity based on the most recent financial
statements of the Company at the time of approval by the Compensation Committee; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">20.3.2.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The Run-Off Policy, as well
as the limit of liability and the premium for each extension or renewal shall be approved by the Compensation Committee (and, if required
by law, by the Board) which shall determine that the sums are reasonable considering the Company&rsquo;s exposures covered under such
policy, the scope of coverage and the market conditions and that the Run-Off Policy reflects the current market conditions and that it
shall not materially affect the Company&rsquo;s profitability, assets or liabilities.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">20.4.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">SciSparc may extend an Insurance
Policy in effect to include coverage for liability pursuant to a future public offering of securities as follows:</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">20.4.1.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The Insurance Policy, as well
as the additional premium shall be approved by the Compensation Committee (and if required by law, by the Board) which shall determine
that the sums are reasonable considering the exposures pursuant to such public offering of securities, the scope of coverage and the
market conditions and that the Insurance Policy reflects the current market conditions, and that it does not materially affect the Company&rsquo;s
profitability, assets or liabilities.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>G.&nbsp;<U>Arrangements upon Change of Control</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: left; "><FONT STYLE="font-size: 10pt">21.</FONT></TD>
    <TD STYLE="text-align: justify; "><FONT STYLE="font-size: 10pt">The following benefits may be granted to the Executive Officers&nbsp;<B>(</B>in addition to, or in lieu of, the benefits applicable in the case of any retirement or termination of service) upon or in connection with a &ldquo;Change of Control&rdquo; or, where applicable, in the event of a Change of Control following which the employment of the Executive Officer is terminated or adversely adjusted in a material way:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">21.1.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Acceleration of vesting of
outstanding options or other equity-based awards;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">21.2.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Extension of the exercise period
of equity-based grants for SciSparc&rsquo;s Executive Officers for a period of up to one (1) year, following the date of termination
of employment; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">21.3.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Up to an additional six (6)
months of continued base salary and benefits following the date of termination of employment (the &ldquo;<B>Additional Adjustment Period</B>&rdquo;).
For avoidance of doubt, such additional Adjustment Period may be in addition to the advance notice and adjustment periods pursuant to
Sections 14 and &lrm;15 of this Policy, but subject to the limitation set forth in Section 18 of this Policy.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">21.4.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">A cash bonus not to exceed
200% of the Executive Officer&rsquo;s annual base salary in case of an Executive Officer other than the CEO and 250% in case of the CEO.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>H.&nbsp;<U>Board of Directors Compensation</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: left; "><FONT STYLE="font-size: 10pt">22.</FONT></TD>
    <TD STYLE="text-align: justify; "><FONT STYLE="font-size: 10pt">All SciSparc&rsquo;s non-employee Board members may be entitled to an annual cash fee retainer of up to $40,000 and up to $240,000 for the President or chairperson of SciSparc&rsquo;s Board. The chairperson of SciSparc&rsquo;s Board and the President may be paid an annual bonus of up to six (6) of his or her monthly cash compensation and up to an additional two (2) monthly cash compensation for overachievement. The discretionary bonus for any given fiscal year will not exceed two (2) monthly cash compensation.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: left; "><FONT STYLE="font-size: 10pt">23.</FONT></TD>
    <TD STYLE="text-align: justify; "><FONT STYLE="font-size: 10pt">The compensation of the Company&rsquo;s external directors, if any are required and elected, shall be in accordance with the Companies Regulations (Rules Regarding the Compensation and Expenses of an External Director), 5760-2000, as amended by the Companies Regulations (Relief for Public Companies Traded in Stock Exchange Outside of Israel), 5760-2000, as such regulations may be amended from time to time.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: left; "><FONT STYLE="font-size: 10pt">24.</FONT></TD>
    <TD STYLE="text-align: justify; "><FONT STYLE="font-size: 10pt">Notwithstanding the provisions of Section 22 above, in special circumstances, such as in the case of a professional director, an expert director or a director who makes a unique contribution to the Company, such director&rsquo;s compensation may be different than the compensation of all other directors and may be greater than the maximum amount allowed under Section 22.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: left; "><FONT STYLE="font-size: 10pt">25.</FONT></TD>
    <TD STYLE="text-align: justify; "><FONT STYLE="font-size: 10pt">Each non-employee member of SciSparc&rsquo;s Board may be granted equity-based compensation. The total fair market value of a &ldquo;welcome&rdquo; or an annual equity-based compensation at the time of grant shall not exceed the higher of (i) $120,000 or (ii) 0.5% of the Company&rsquo;s fair market value at the time of approval of the grant by the Board; and in the case of the President and chairperson of the Board - the higher of (i) 300% of his or her annual base salary or (ii) 2% of the Company&rsquo;s fair market value at the time of approval of the grant by the Board.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: left; "><FONT STYLE="font-size: 10pt">26.</FONT></TD>
    <TD STYLE="text-align: justify; "><FONT STYLE="font-size: 10pt">All other terms of the equity awards shall be in accordance with SciSparc&rsquo;s incentive plans and other related practices and policies. Accordingly, the Board may, following approval by the Compensation Committee, make modifications to such awards consistent with the terms of such incentive plans, subject to any additional approval as may be required by the Companies Law.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: left; "><FONT STYLE="font-size: 10pt">27.</FONT></TD>
    <TD STYLE="text-align: justify; "><FONT STYLE="font-size: 10pt">In addition, members of SciSparc&rsquo;s Board may be entitled to reimbursement of expenses in connection with the performance of their duties.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: left; "><FONT STYLE="font-size: 10pt">28.</FONT></TD>
    <TD STYLE="text-align: justify; "><FONT STYLE="font-size: 10pt">The compensation (and limitations) stated under Section H will not apply to directors who serve as Executive Officers.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>I.&nbsp;<U>Miscellaneous</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: left; "><FONT STYLE="font-size: 10pt">29.</FONT></TD>
    <TD STYLE="text-align: justify; "><FONT STYLE="font-size: 10pt">Nothing in this Policy shall be deemed to grant to any of SciSparc&rsquo;s Executive Officers, employees, directors, or any third party any right or privilege in connection with their employment by or service to the Company, nor deemed to require SciSparc to provide any compensation or benefits to any person. Such rights and privileges shall be governed by applicable personal employment agreements or other separate compensation arrangements entered into between SciSparc and the recipient of such compensation or benefits. The Board may determine that none or only part of the payments, benefits and perquisites detailed in this Policy shall be granted, and is authorized to cancel or suspend a compensation package or any part of it.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: left; "><FONT STYLE="font-size: 10pt">30.</FONT></TD>
    <TD STYLE="text-align: justify; "><FONT STYLE="font-size: 10pt">An Immaterial Change in the Terms of Employment of an Executive Officer other than the CEO may be approved by the CEO, provided that the amended terms of employment are in accordance with this Policy. An &ldquo;Immaterial Change in the Terms of Employment&rdquo; means a change in the terms of employment of an Executive Officer with an annual total cost to the Company not exceeding an amount equal to two (2) monthly base salaries of such employee.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; text-align: left; "><FONT STYLE="font-size: 10pt">31.</FONT></TD>
    <TD STYLE="text-align: justify; "><FONT STYLE="font-size: 10pt">In the event that new regulations or law amendment in connection with Executive Officers&rsquo; and directors&rsquo; compensation will be enacted following the adoption of this Policy, SciSparc may follow such new regulations or law amendments, even if such new regulations are in contradiction to the compensation terms set forth herein.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">*********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This Policy is designed solely for the benefit
of SciSparc and none of the provisions thereof are intended to provide any rights or remedies to any person other than SciSparc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">A-9</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>ea024305301ex99-2_scisparc.htm
<DESCRIPTION>PROXY CARD FOR THE ANNUAL GENERAL MEETING TO BE HELD ON JUNE 25, 2025
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY>

    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><B>Exhibit 99.2</B></P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%">
  <TR>
    <TD STYLE="vertical-align: top; width: 50%">
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><I>SCISPARC LTD.</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><I>20 Raul Wallenberg Street, Tower A </I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><I>Tel Aviv 6971916 Israel.</I></P></TD>
    <TD STYLE="width: 50%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>VOTE BY INTERNET -&nbsp;<U>www.proxyvote.com</U></B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Use the Internet to transmit your voting instructions
    and for electronic delivery of information up until 11:59 p.m. Eastern Time, June 24, 2025. Have your proxy card in hand when you access
    the web site and follow the instructions to obtain your records and to create an electronic voting instruction form.</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>ELECTRONIC DELIVERY OF FUTURE PROXY MATERIALS</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If you would like to reduce the costs incurred
    by our company in mailing proxy materials, you can consent to receiving all future proxy statements, proxy cards and annual reports electronically
    via e-mail or the Internet. To sign up for electronic delivery, please follow the instructions above to vote using the Internet and, when
    prompted, indicate that you agree to receive or access proxy materials electronically in future years.</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>VOTE BY PHONE - 1-800-690-6903</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Use any touch-tone telephone to transmit your
    voting instructions up until 11:59 p.m. Eastern Time, June 24, 2025. Have your proxy card in hand when you call and then follow the instructions.</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>VOTE BY MAIL</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mark, sign and date your proxy card and return
    it in the postage-paid envelope we have provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717.</P></TD></TR>
  </TABLE>
<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%">
  <TR>
    <TD STYLE="font: 9pt Times New Roman, Times, Serif; vertical-align: top; width: 50%; border-bottom: black 1.5pt dashed; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">TO
    VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS:</FONT></TD>
    <TD STYLE="font: 9pt Times New Roman, Times, Serif; width: 50%; border-bottom: black 1.5pt dashed; padding: 1.5pt"><P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT>KEEP
THIS PORTION FOR YOUR RECORDS</P></TD></TR>
  <TR STYLE="font: 9pt Times New Roman, Times, Serif">
    <TD STYLE="font: 9pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 9pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">DETACH AND
    RETURN THIS PORTION ONLY</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND
DATED.</B></P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt"><B>SCISPARC LTD.</B></FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify"><B>The Board of Directors
recommends you vote FOR the following proposals:</B>&nbsp;</P>

</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%">1.</TD>
    <TD STYLE="text-align: justify; width: 58%"><FONT STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">    </FONT>To re-elect each of Mr. Alon Dayan, Mr. Moshe Revach and Mr. Lior Vider to serve as Class II directors of the Company, until the Company&rsquo;s third annual general meeting of shareholders following this Meeting, and until their respective successor is duly elected and qualified.</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center; width: 13%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; width: 13%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; width: 13%">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt"><B>Nominees: </B></FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt"><B>For</B></FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt"><B>Against</B></FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt"><B>Abstain</B></FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>1a.</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"> Alon Dayan</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>1b.</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"> Moshe Revach</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>1c.</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"> Lior Vider</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>2.</TD>
    <TD STYLE="text-align: justify">To approve an increase to the Company&rsquo;s authorized share capital and to amend the Company&rsquo;s
amended and restated articles of association accordingly.</TD>
    <TD STYLE="vertical-align: top; text-align: center">&#9744;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&#9744;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&#9744;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>3.</TD>
    <TD STYLE="text-align: justify">To approve a reverse split of the Company&rsquo;s issued and outstanding ordinary shares in the range of a ratio between 1:2 and
    1:250, to be effected at the discretion of, at such ratio within the range and by such number of increments, and on such dates, as may
    be determined by the Company&rsquo;s board of directors within 18 months following the date of the Meeting.</TD>
    <TD STYLE="vertical-align: top; text-align: center">&#9744;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&#9744;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&#9744;</TD></TR>

  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>4.<FONT STYLE="font-family: Times New Roman, Times, Serif">
    </FONT></TD>
    <TD STYLE="text-align: justify">To
approve the re-adoption of the compensation policy for the Company&rsquo;s executive officers and directors.</TD>
    <TD STYLE="vertical-align: top; text-align: center">&#9744;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&#9744;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&#9744;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>5. </TD>
    <TD STYLE="text-align: justify">To
re-appoint Kost, Forer, Gabbay &amp; Kasierer, a member of Ernst &amp; Young Global, as the Company&rsquo;s independent registered public
accounting firm for the year ending December 31, 2025 and until the next annual general meeting of shareholders, and to authorize the
Company&rsquo;s board of directors (with power of delegation to its audit committee) to set the fees to be paid to such auditors.&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&#9744;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&#9744;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&#9744;</TD></TR>
</TABLE>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Please sign exactly
as your name(s) appear(s) hereon. When signing as attorney, executor, administrator, or other fiduciary, please give full title as such.
Joint owners should each sign personally. All holders must sign. If a corporation or partnership, please sign in full corporate or partnership
name by authorized officer.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
  <TR>
    <TD STYLE="width: 2%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 35%; border: black 1.5pt solid; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 5%; border-top: black 1.5pt solid; border-right: black 1.5pt solid; border-bottom: black 1.5pt solid; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 35%; border: black 1.5pt solid; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 5%; border-top: black 1.5pt solid; border-right: black 1.5pt solid; border-bottom: black 1.5pt solid; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: left">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Signature [PLEASE SIGN WITHIN BOX]</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Date</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Signature (Joint Owners)</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Date</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Important Notice Regarding the Availability
of Proxy Materials for the Annual General Meeting:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The Proxy Statement is available at www.proxyvote.com.</P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
  <TR>
    <TD STYLE="vertical-align: top; width: 50%; border-bottom: black 1.5pt dashed; padding: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 50%; border-bottom: black 1.5pt dashed; padding: 1.5pt">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SCISPARC LTD.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Annual General Meeting of Shareholders</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>To be held June 25, 2025 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>This proxy is solicited by the Board of Directors</B></P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The undersigned shareholder(s) hereby appoint(s)
Oz Adler and Amitay Weiss, and each of them, as proxies and attorneys-in-fact, each with the power to appoint (his/her) substitute or
successive substitutes, and hereby authorize(s) them to represent and to vote, as designated on the reverse side of this ballot, all of
the ordinary shares of SciSparc Ltd. that the shareholder(s) is/are entitled to vote at the Annual General Meeting of Shareholders to
be held at 3:00 PM (Israel time) on June 25, 2025, at 20 Raul Wallenberg Street, Tower A Tel Aviv 6971916 Israel, and in their discretion,
according to their best judgment and the recommendation of the board of directors, to vote upon such other business as may properly come
before the meeting, any adjournment(s) or postponement(s) thereof. The undersigned shareholder(s) also acknowledge(s) receipt of the Notice
of Annual General Meeting of Shareholders and the Company&rsquo;s Proxy Statement, dated May 21, 2025, for such meeting (including either
a physical copy or by way of electronic access).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>IMPORTANT NOTE</U>: BY EXECUTING THIS PROXY
CARD, THE UNDERSIGNED SHAREHOLDER IS CONFIRMING THAT HE, SHE OR IT DOES NOT HAVE A CONFLICT OF INTEREST (I.E., THE UNDERSIGNED IS NOT
AN &ldquo;INTERESTED SHAREHOLDER&rdquo;) IN THE APPROVAL OF PROPOSAL NO. 4 AND CAN THEREFORE BE COUNTED TOWARDS OR AGAINST THE MAJORITY
REQUIRED FOR APPROVAL OF THAT PROPOSAL. IF YOU HAVE SUCH A CONFLICT OF INTEREST IN THE APPROVAL OF PROPOSAL NO. 4, PLEASE NOTIFY MR. OZ
ADLER, THE COMPANY&rsquo;S CHIEF EXECUTIVE OFFICER, AT 20 RAUL WALLENBERG STREET, TOWER A TEL AVIV 6971916, ISRAEL, TELEPHONE: <FONT STYLE="font-size: 10pt">+</FONT>972-3-7175777
OR EMAIL OZ@SCISPARC.COM.</B></P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt">This proxy also delegates,
to the extent permitted by applicable law, discretionary authority to vote with respect to any other business which may properly come
before the annual general meeting or any adjournment(s) or postponement(s) thereof.</P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">WHETHER OR NOT YOU EXPECT TO ATTEND THE MEETING,
PLEASE COMPLETE, DATE AND SIGN THIS FORM OF PROXY AND MAIL THE ENTIRE PROXY PROMPTLY, ALONG WITH PROOF OF IDENTITY IN ACCORDANCE WITH
THE COMPANY&rsquo;S PROXY STATEMENT, IN THE ENCLOSED ENVELOPE IN ORDER TO ASSURE REPRESENTATION OF THESE SHARES. NO POSTAGE NEED BE AFFIXED
IF THE PROXY IS MAILED IN THE UNITED STATES.</P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>This proxy, when properly executed, will be
voted in the manner directed herein. If no such direction is made, this proxy will be voted in accordance with the Board of Directors&rsquo;
recommendations.</B></P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Continued and to be signed on reverse side</B></P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>





</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>ex99-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !Q &L# 2(  A$! Q$!_\0
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MO%DUMX*^*>J_$WQIX[M/ T/B[4I]0\/^ +GPEXZ_M3P_J6KVNDP/YA+\8O\
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M(!=VMM="VN8;RV%S!%.+>[MV+6]U )5;RKF!B6AGCVRQ,2492:LT44 %%%%
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,4 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
